NCT03857061Completed
A Wearable and a Self-management Application for Chronic Obstructive Pulmonary Disease (COPD) Patients at Home
COPDwear V2 - A Wearable and a Self-management Application for COPD Patients at Home: a Pilot Prospective Cohort Study
Source: ClinicalTrials.gov · Last updated 24 Jan 2025
Brief summary (registry, in English)
Our overall research goal for this project is to create a wearable device and mobile application, appealing to patients with Chronic Obstructive Pulmonary Disease (COPD), which provides them with appropriate self-management tools and detects AECOPDs early to permit prompt treatment and prevent severe exacerbations requiring hospitalization.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 30 (actual)
- First submitted
- 23 Jul 2018
- Start date
- 29 Jun 2019
- Primary completion date
- 1 Jun 2021
- Lead sponsor
- University Health Network, Toronto
- Diseases
- COPD
- NCT number
- NCT03857061
What you commit to
- Study type: Observational
- Participants enrolled: 30
- From 29 Jun 2019 to the primary completion date, 1 Jun 2021
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Pulmonary condition other than COPD as the main respiratory disease such as bronchiectasis or asthma
- Rapid lethal disease, e.g. lung cancer, advance heart failure, end-stage renal disease
- Any medical conditions that would impair their ability to participate in the study
Who the study is looking for
- Able to speak English
- Moderate to very severe COPD (GOLD C and D) as defined by the GOLD guidelines
- Clinically relevant disease, as defined by a history of exacerbation in the previous 12 months
- Previous spirometry or Pulmonary Function Test results of Forced Expiration Volume/Forced Vital Capacity (FEV1/FVC) \<0.70 with an FEV1 below 80% predicted
- Patient resides at home (not long term care residence or another hospital)
Age in the registry: 40 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Toronto General Hospital Coordinator of this site? Confirm its status | Toronto | Canada | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.